There have been 47,220 gun incidents in the U.S. in 2018 and here they all are on one map
So far this year, guns have killed 11,984 people
All Posts in "Markets"
Stocks could rally 20% after this bruising rout, says Guggenheim’s Minerd — after that, watch out
Minerd predicts that the U.S. stock market will fall 40% or 50% after they surge
Stop blaming computer programs for steep drops in the stock market
Worry instead about the impact of some newer products
Apple earnings: Can pricey new phones carry the holidays?
China concerns will also be in focus during Apple’s earnings call Thursday
Amazon was primed to join Apple with $1 trillion in market cap — now it’s worth less than Microsoft
Amazon’s valuation has lost almost $200 billion in six weeks, falling behind cloud rival Microsoft
Trade worries weigh down Asia stocks despite big rebound in U.S.
Stocks in Asia fell Friday, following a week an up-and-down few days that has left most indexes far in the red for the week. The losses came in the face of a recovery in U.S. equity markets Thursday that followed a big selloff Wednesday.
Here’s a reminder that stock-market corrections don’t always become bear markets
BAML’s Subramanian thinks the next bear market is 21 months away
What should retirees do if the market goes against them?
The stock market has defied predictions
U.S. stock futures under pressure after Amazon, Google disappoint
U.S. stocks were poised to come under pressure on Friday, threatening to give back some of the previous session’s rally in a week marked by sharp volatility that has pushed the major indexes in and out of negative territory for the year.
Fed’s Beige Book says wages, prices growing at ‘modest to moderate’ rates
Labor markets remain tight throughout the country
Despite cash infusion, Windtree still faces money running out within a year
Pain medicine biotech Latigo taps CRO founder for CMO role
Johnson & Johnson to buy heart failure implant company V-Wave for up to $1.7B
Talus Bio tacks on $11M to target hard-to-reach transcription factors
Pathalys raises $105M series B to prepare Japan-approved kidney disease drug for FDA
Denmark’s Adcendo signs $1B biobuck deal for Multitude’s anti-TF ADC
Merck & Co. bags one Kelun ADC for $37.5M, boots out another asset as pipeline tinkering continues
Avantor sells clinical services unit to private equity firm for $650M
‘We’re pretty prolific’: Lilly Catalyze360 looks to connect with emerging biotechs across ‘all areas’
FDA clears its first at-home blood test for syphilis